Year |
Citation |
Score |
2024 |
Stoops WW, Shellenberg TP, Regnier SD, Cox DH, Adatorwovor R, Hays LR, Anderson DM, Lile JA, Schmitz JM, Havens JR, Segerstrom SC. Influence of cocaine use reduction on markers of immune function. Journal of Neuroimmunology. 397: 578470. PMID 39504756 DOI: 10.1016/j.jneuroim.2024.578470 |
0.637 |
|
2023 |
Regnier SD, Shellenberg TP, Koffarnus MN, Cox DH, Lile JA, Rush CR, Stoops WW. Cocaine abstinence during the "critical period" of a contingency management trial predicts future abstinence in people with cocaine use disorder. Drug and Alcohol Dependence. 253: 111030. PMID 38006674 DOI: 10.1016/j.drugalcdep.2023.111030 |
0.545 |
|
2023 |
Strickland JC, Hatton KW, Hays LR, Rayapati AO, Lile JA, Rush CR, Stoops WW. Use of drug purchase tasks in medications development research: orexin system regulation of cocaine and drug demand. Behavioural Pharmacology. 34: 275-286. PMID 37403694 DOI: 10.1097/FBP.0000000000000731 |
0.657 |
|
2023 |
Regnier SD, Stoops WW, Lile JA, Alcorn JL, Bolin BL, Reynolds AR, Hays LR, Rayapati AO, Rush CR. Naltrexone-bupropion combinations do not affect cocaine self-administration in humans. Pharmacology, Biochemistry, and Behavior. 224: 173526. PMID 36805862 DOI: 10.1016/j.pbb.2023.173526 |
0.717 |
|
2022 |
Stoops WW, Strickland JC, Hatton KW, Hays LR, Rayapati AO, Lile JA, Rush CR. Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans. Pharmacology, Biochemistry, and Behavior. 220: 173466. PMID 36152876 DOI: 10.1016/j.pbb.2022.173466 |
0.768 |
|
2022 |
Regnier SD, Lile JA, Rush CR, Stoops WW. Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies. Journal of the Experimental Analysis of Behavior. PMID 35229294 DOI: 10.1002/jeab.744 |
0.702 |
|
2020 |
Rush CR, Stoops WW, Lile JA, Alcorn JL, Bolin BL, Reynolds AR, Hays LR, Rayapati AO. Topiramate-phentermine combinations reduce cocaine self-administration in humans. Drug and Alcohol Dependence. 218: 108413. PMID 33290875 DOI: 10.1016/j.drugalcdep.2020.108413 |
0.652 |
|
2020 |
Shellenberg TP, Stoops WW, Lile JA, Rush CR. An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. Expert Review of Clinical Pharmacology. 1-9. PMID 32715789 DOI: 10.1080/17512433.2020.1796636 |
0.462 |
|
2020 |
Alcorn JL, Strickland JC, Lile JA, Stoops WW, Rush CR. Acute methylphenidate administration reduces cocaine-cue attentional bias. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109974. PMID 32454161 DOI: 10.1016/J.Pnpbp.2020.109974 |
0.673 |
|
2019 |
Lile JA, Johnson AR, Banks ML, Hatton KW, Hays LR, Nicholson KL, Poklis JL, Rayapati AO, Rush CR, Stoops WW, Negus SS. Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys. Experimental and Clinical Psychopharmacology. PMID 31259593 DOI: 10.1037/Pha0000302 |
0.777 |
|
2019 |
Stoops WW, Strickland JC, Alcorn JL, Hays LR, Rayapati AO, Lile JA, Rush CR. Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine. Psychopharmacology. PMID 30900008 DOI: 10.1007/S00213-019-05227-X |
0.739 |
|
2018 |
Alcorn JL, Marks KR, Stoops WW, Rush CR, Lile JA. Attentional bias to cannabis cues in cannabis users but not cocaine users. Addictive Behaviors. 88: 129-136. PMID 30176501 DOI: 10.1016/J.Addbeh.2018.08.023 |
0.316 |
|
2018 |
Strickland JC, Marks KR, Beckmann JS, Lile JA, Rush CR, Stoops WW. Contribution of cocaine-related cues to concurrent monetary choice in humans. Psychopharmacology. PMID 30046863 DOI: 10.1007/S00213-018-4978-5 |
0.399 |
|
2017 |
Reynolds AR, Strickland JC, Stoops WW, Lile JA, Rush CR. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. Drug and Alcohol Dependence. 181: 25-29. PMID 29028556 DOI: 10.1016/J.Drugalcdep.2017.08.038 |
0.33 |
|
2017 |
Bolin BL, Alcorn JL, Lile JA, Rush CR, Rayapati AO, Hays LR, Stoops WW. N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. Drug and Alcohol Dependence. 178: 452-460. PMID 28711811 DOI: 10.1016/J.Drugalcdep.2017.05.039 |
0.731 |
|
2017 |
Alcorn JL, Pike E, Stoops WS, Lile JA, Rush CR. A pilot investigation of acute inhibitory control training in cocaine users. Drug and Alcohol Dependence. 174: 145-149. PMID 28329718 DOI: 10.1016/J.Drugalcdep.2017.01.014 |
0.569 |
|
2017 |
Stoops WW, Lile JA, Hays LR, Rayapati AO, Rush CR. Safety and tolerability of cocaine during phendimetrazine maintenance Drug and Alcohol Dependence. 171: e197-e198. DOI: 10.1016/J.Drugalcdep.2016.08.540 |
0.656 |
|
2017 |
Alcorn JL, Pike E, Lile JA, Stoops WW, Rush CR. Acute inhibitory control training in cocaine users Drug and Alcohol Dependence. 171: e5. DOI: 10.1016/J.Drugalcdep.2016.08.029 |
0.515 |
|
2016 |
Strickland JC, Lile JA, Rush CR, Stoops WW. Comparing exponential and exponentiated models of drug demand in cocaine users. Experimental and Clinical Psychopharmacology. 24: 447-455. PMID 27929347 DOI: 10.1037/Pha0000096 |
0.468 |
|
2016 |
Harvanko A, Martin C, Lile J, Kryscio R, Kelly TH. Individual differences in the reinforcing and subjective effects of d-amphetamine: Dimensions of impulsivity. Experimental and Clinical Psychopharmacology. 24: 436-446. PMID 27929346 DOI: 10.1037/Pha0000095 |
0.331 |
|
2016 |
Strickland JC, Bolin BL, Lile JA, Rush CR, Stoops WW. Differential sensitivity to learning from positive and negative outcomes in cocaine users. Drug and Alcohol Dependence. PMID 27373186 DOI: 10.1016/J.Drugalcdep.2016.06.022 |
0.402 |
|
2016 |
Lile JA, Stoops WW, Rush CR, Negus SS, Glaser PE, Hatton KW, Hays LR. Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug and Alcohol Dependence. PMID 27269368 DOI: 10.1016/J.Drugalcdep.2016.05.022 |
0.606 |
|
2016 |
Johnson AR, Banks ML, Blough BE, Lile JA, Nicholson KL, Negus SS. Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys. Drug and Alcohol Dependence. PMID 27264165 DOI: 10.1016/j.drugalcdep.2016.05.021 |
0.747 |
|
2016 |
Bolin BL, Lile JA, Marks KR, Beckmann JS, Rush CR, Stoops WW. Buspirone reduces sexual risk-taking intent but not cocaine self-administration. Experimental and Clinical Psychopharmacology. 24: 162-73. PMID 27254258 DOI: 10.1037/Pha0000076 |
0.607 |
|
2016 |
Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Journal of Clinical Psychopharmacology. PMID 27043121 DOI: 10.1097/Jcp.0000000000000488 |
0.342 |
|
2016 |
Stoops WW, Strickland JC, Hays LR, Rayapati AO, Lile JA, Rush CR. Safety and tolerability of intranasal cocaine during phendimetrazine maintenance. Psychopharmacology. PMID 26932737 DOI: 10.1007/S00213-016-4260-7 |
0.709 |
|
2015 |
Bolin BL, Lile JA, Marks KR, Rush CR, Stoops WW. Influence of buspirone maintenance on the pharmacodynamic effects of cocaine and sexual risk taking in cocaine users Drug and Alcohol Dependence. 156: e23. DOI: 10.1016/J.Drugalcdep.2015.07.981 |
0.644 |
|
2015 |
Lile JA, Negus S, Stoops WW, Johnson A, Kate N, Banks M, Rush CR, Hays L, Glaser P. Coordinated and homologous intravenous cocaine self-administration procedures in monkeys and humans: A translational approach to medications development Drug and Alcohol Dependence. 156: e129. DOI: 10.1016/J.Drugalcdep.2015.07.354 |
0.595 |
|
2014 |
Strickland JC, Lile JA, Rush CR, Stoops WW. Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules. Human Psychopharmacology. 29: 342-50. PMID 25163439 DOI: 10.1002/Hup.2409 |
0.562 |
|
2013 |
Stoops WW, Bennett JA, Lile JA, Sevak RJ, Rush CR. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 47: 111-7. PMID 23994622 DOI: 10.1016/J.Pnpbp.2013.08.007 |
0.337 |
|
2013 |
Lile JA, Charnigo RJ, Nader MA. The relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine. Behavioural Pharmacology. 24: 482-5. PMID 23907377 DOI: 10.1097/Fbp.0B013E3283644D44 |
0.75 |
|
2012 |
Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction (Abingdon, England). 107: 1140-7. PMID 22168398 DOI: 10.1111/J.1360-0443.2011.03766.X |
0.716 |
|
2012 |
Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Alternative reinforcer response cost impacts cocaine choice in humans. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 36: 189-93. PMID 22015480 DOI: 10.1016/J.Pnpbp.2011.10.003 |
0.71 |
|
2011 |
Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacology, Biochemistry, and Behavior. 100: 40-7. PMID 21802442 DOI: 10.1016/J.Pbb.2011.06.024 |
0.352 |
|
2011 |
Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology. 214: 665-74. PMID 21072503 DOI: 10.1007/S00213-010-2067-5 |
0.364 |
|
2011 |
Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. Journal of Psychopharmacology (Oxford, England). 25: 1469-79. PMID 20952456 DOI: 10.1177/0269881110385597 |
0.718 |
|
2011 |
Lile JA, Babalonis S, Emurian C, Martin CA, Wermeling DP, Kelly TH. Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects. Journal of Clinical Pharmacology. 51: 888-98. PMID 20671295 DOI: 10.1177/0091270010375956 |
0.337 |
|
2010 |
Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. European Journal of Pharmacology. 644: 101-5. PMID 20638380 DOI: 10.1016/J.Ejphar.2010.06.055 |
0.768 |
|
2010 |
Stoops WW, Lile JA, Rush CR. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacology, Biochemistry, and Behavior. 95: 187-91. PMID 20109483 DOI: 10.1016/J.Pbb.2010.01.003 |
0.725 |
|
2008 |
Lile JA, Stoops WW, Hays LR, Rush CR. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. The American Journal of Drug and Alcohol Abuse. 34: 721-9. PMID 18855244 DOI: 10.1080/00952990802308262 |
0.716 |
|
2007 |
Stoops WW, Lile JA, Lofwall MR, Rush CR. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. The American Journal of Drug and Alcohol Abuse. 33: 769-76. PMID 17994473 DOI: 10.1080/00952990701651556 |
0.725 |
|
2007 |
Lile JA, Kendall SL, Babalonis S, Martin CA, Kelly TH. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacology, Biochemistry, and Behavior. 87: 258-66. PMID 17544491 DOI: 10.1016/j.pbb.2007.04.022 |
0.316 |
|
2007 |
Stoops WW, Vansickel AR, Lile JA, Rush CR. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacology, Biochemistry, and Behavior. 87: 20-9. PMID 17490738 DOI: 10.1016/J.Pbb.2007.03.016 |
0.507 |
|
2007 |
Stoops WW, Lile JA, Robbins CG, Martin CA, Rush CR, Kelly TH. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addictive Behaviors. 32: 1177-88. PMID 17011712 DOI: 10.1016/J.Addbeh.2006.08.006 |
0.358 |
|
2006 |
Lile JA, Stoops WW, Durell TM, Glaser PE, Rush CR. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology. 14: 136-47. PMID 16756417 DOI: 10.1037/1064-1297.14.2.136 |
0.391 |
|
2006 |
Claytor R, Lile JA, Nader MA. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 83: 456-64. PMID 16631246 DOI: 10.1016/J.Pbb.2006.03.007 |
0.736 |
|
2006 |
Stoops WW, Lile JA, Glaser PE, Rush CR. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug and Alcohol Dependence. 84: 206-9. PMID 16540264 DOI: 10.1016/J.Drugalcdep.2006.02.004 |
0.483 |
|
2006 |
Lile JA. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment. Experimental and Clinical Psychopharmacology. 14: 20-33. PMID 16503702 DOI: 10.1037/1064-1297.14.1.20 |
0.427 |
|
2005 |
Lile JA, Stoops WW, Wagner FP, Glaser PE, Rush CR. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacology, Biochemistry, and Behavior. 82: 270-9. PMID 16182353 DOI: 10.1016/J.Pbb.2005.08.012 |
0.322 |
|
2005 |
Lile JA, Stoops WW, Vansickel AR, Glaser PE, Hays LR, Rush CR. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2103-14. PMID 15988473 DOI: 10.1038/Sj.Npp.1300803 |
0.434 |
|
2005 |
Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology. 182: 186-93. PMID 15986191 DOI: 10.1007/S00213-005-0044-1 |
0.321 |
|
2005 |
Lile JA, Ross JT, Nader MA. A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug and Alcohol Dependence. 78: 135-40. PMID 15845316 DOI: 10.1016/J.Drugalcdep.2004.10.006 |
0.783 |
|
2005 |
Stoops WW, Lile JA, Glaser PE, Rush CR. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology. 13: 56-64. PMID 15727504 DOI: 10.1037/1064-1297.13.1.56 |
0.375 |
|
2005 |
Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology. 177: 349-55. PMID 15609070 DOI: 10.1007/S00213-004-1946-Z |
0.529 |
|
2004 |
Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug and Alcohol Dependence. 76: 81-91. PMID 15380292 DOI: 10.1016/J.Drugalcdep.2004.04.010 |
0.748 |
|
2004 |
Lile JA, Morgan D, Birmingham AM, Davies HM, Nader MA. Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys. Psychopharmacology. 174: 246-53. PMID 14735291 DOI: 10.1007/S00213-003-1738-X |
0.764 |
|
2004 |
Lile JA, Stoops WW, Allen TS, Glaser PE, Hays LR, Rush CR. Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology. 171: 441-9. PMID 14504683 DOI: 10.1007/S00213-003-1598-4 |
0.759 |
|
2003 |
Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, Nader MA. The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. The Journal of Pharmacology and Experimental Therapeutics. 307: 356-66. PMID 12954808 DOI: 10.1124/Jpet.103.049825 |
0.744 |
|
2002 |
Lile JA, Morgan D, Birmingham AM, Wang Z, Woolverton WL, Davies HM, Nader MA. The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 303: 640-8. PMID 12388646 DOI: 10.1124/Jpet.102.039180 |
0.798 |
|
2000 |
Lile JA, Morgan D, Freedland CS, Sinnott RS, Davies HM, Nader MA. Self-administration of two long-acting monoamine transport blockers in rhesus monkeys. Psychopharmacology. 152: 414-21. PMID 11140334 DOI: 10.1007/S002130000554 |
0.772 |
|
2000 |
Lile JA, Morgan D, Nader MA. First- versus last-session substitution: an evaluation of the reinforcing effects of cocaine and the cocaine analogue 2beta-propanoyl-3beta-(4-tolyl)-tropane. Experimental and Clinical Psychopharmacology. 8: 424-33. PMID 10975634 DOI: 10.1037//1064-1297.8.3.424 |
0.783 |
|
1999 |
Lile JA. AN ALTERATION IN THE SELF-ADMINISTRATION OF TWO NOVEL TROPANE ANALOGS IN RHESUS MONKEYS FOLLOWING COCAINE EXPOSURE Behavioural Pharmacology. 10: S58. DOI: 10.1097/00008877-199908001-00146 |
0.658 |
|
Show low-probability matches. |